Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
- Status
- RECRUITING
- Phase
- PHASE3
FL-261 Imaging for Cancer Diagnosis and Staging
- Status
- RECRUITING
- Phase
- N/A
Yittrium-90(Y-90) Fibroblast Activation Protein Inhibitor (FAPI) Therapy in Patients With Non-Small Cell Lung Cancer (Phase II)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
FAP-targeted PET/NIR in Lung Malignant Tumors
- Status
- RECRUITING
- Phase
- N/A
Family-Supported Palliative Care in Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- NA
A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
- Status
- RECRUITING
- Phase
- N/A
Boosting Osimertinib Blood Brain Barrier Penetration
- Status
- RECRUITING
- Phase
- PHASE2
Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLC
- Status
- RECRUITING
- Phase
- NA
Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Liquid Biopsy Monitoring Of EGFR T790M in Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
SYS6090 Combination Therapy in Advanced Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase III Study of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
An Open-Label, Single-Arm, Dose-Escalation Phase I Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of EDB-102 in Patients With EGFR L858R-Mutant, Third-Generation TKI-Resistant Advanced Non-Small Cell Lung Cancer With Liver Metastases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Singing Training vs Usual Care 6-18 Months After Surgical Resection for Non-small Cell Lung Cancer (NSCLC)
- Status
- RECRUITING
- Phase
- NA
An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLC
- Status
- RECRUITING
- Phase
- NA